We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
+8.8%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$83B
AUM Growth
+$4.08B
Cap. Flow
-$2.07B
Cap. Flow %
-2.5%
Top 10 Hldgs %
13.18%
Holding
730
New
59
Increased
161
Reduced
398
Closed
45

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$433M
2
LOW icon
Lowe's Companies
LOW
+$277M
3
ORCL icon
Oracle
ORCL
+$226M
4
PGR icon
Progressive
PGR
+$220M
5
LVS icon
Las Vegas Sands
LVS
+$167M

Sector Composition

Rank Sector Weight
1 Financials 19.96%
2 Healthcare 15.3%
3 Industrials 15.12%
4 Technology 14.91%
5 Consumer Discretionary 11.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABCB icon
326
Ameris Bancorp
ABCB
$5.77B
$18M 0.02%
358,447
-3,443
-1% -$178K
SCS
327
DELISTED
Steelcase
SCS
$17.9M 0.02%
+1,525,773
New +$18.4M
MO icon
328
Altria Group
MO
$122B
$17.9M 0.02%
377,543
-19,905
-5% -$912K
WERN icon
329
Werner Enterprises
WERN
$2.42B
$17.7M 0.02%
373,245
-3,173
-0.8% -$145K
AEO icon
330
American Eagle Outfitters
AEO
$2.98B
$17.4M 0.02%
+690,293
New +$17.6M
IWD icon
331
iShares Russell 1000 Value ETF
IWD
$81.5B
$17.4M 0.02%
103,378
+58,558
+131% +$9.59M
COLB icon
332
Columbia Banking Systems
COLB
$8.74B
$17.4M 0.02%
+525,416
New +$18.2M
NESR
333
National Energy Services Reunited Corp
NESR
$2.71B
$16.9M 0.02%
1,779,826
-230,630
-11% -$2.58M
TEX icon
334
Terex
TEX
$7.89B
$16.6M 0.02%
374,994
-2,627
-0.7% -$118K
HAE icon
335
Haemonetics
HAE
$3.63B
$15.9M 0.02%
300,588
-4,621
-2% -$282K
AES icon
336
AES
AES
$10.6B
$15.8M 0.02%
649,297
+228,015
+54% +$5.54M
HRB icon
337
H&R Block
HRB
$5.37B
$15.6M 0.02%
662,282
+136,075
+26% +$3.3M
MTX icon
338
Minerals Technologies
MTX
$2.29B
$15.1M 0.02%
205,557
-1,623
-0.8% -$117K
BLDR icon
339
Builders FirstSource
BLDR
$7.82B
$14.9M 0.02%
174,165
-906
-0.5% -$61.4K
SMP icon
340
Standard Motor Products
SMP
$867M
$14.9M 0.02%
283,833
-1,669
-0.6% -$83.7K
MSFT icon
341
Microsoft
MSFT
$2.89T
$14.7M 0.02%
44,158
-3,696
-8% -$1.2M
WBS icon
342
Webster Financial
WBS
$12.5B
$13.4M 0.02%
240,596
+101
+0% +$5.69K
NEX
343
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$13.4M 0.02%
3,556,767
+365,275
+11% +$1.53M
ECVT icon
344
Ecovyst
ECVT
$1.34B
$13.4M 0.02%
1,309,504
+34,453
+3% +$377K
CHE icon
345
Chemed
CHE
$6.76B
$13.1M 0.02%
+24,757
New +$11.9M
INGR icon
346
Ingredion
INGR
$6.4B
$12.7M 0.02%
+131,240
New +$12.6M
KFY icon
347
Korn Ferry
KFY
$4.13B
$12.3M 0.01%
162,001
-102,555
-39% -$7.88M
ACRE
348
Ares Commercial Real Estate
ACRE
$257M
$12.1M 0.01%
832,565
-4,549
-0.5% -$69.4K
FCNCA icon
349
First Citizens BancShares
FCNCA
$24.3B
$11.9M 0.01%
14,397
+83
+0.6% +$69.2K
NEUE
350
DELISTED
NeueHealth
NEUE
$11.9M 0.01%
+43,640
New +$20.1M

Similar funds

Boston Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Boston Partners held 730 positions worth $83B, up 5.2% from $78.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Boston Partners's Q4 2021 filing shows 59 new, 161 increased, 398 reduced and 45 closed positions. Its largest new stake was Keurig Dr Pepper: 15,605,496 shares worth $575M. The largest sale was Pfizer, an estimated $433M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Industrials.

  • Boston Partners's largest Q4 2021 buy was Keurig Dr Pepper: 15,605,496 shares worth $575M.
  • Boston Partners added most to Fidelity National Information Services in Q4 2021, an estimated $353M increase.
  • Boston Partners's biggest Q4 2021 reduction was Pfizer, cutting an estimated $433M.
  • Boston Partners fully exited CyrusOne Inc Common Stock in Q4 2021, selling an estimated $137M.
  • Boston Partners's ten largest holdings make up 13% of its $83B portfolio in Q4 2021.
  • Boston Partners opened 59 new positions and closed 45 in Q4 2021.
  • Boston Partners's portfolio value rose 5.2% quarter-over-quarter to $83B.

Based on Boston Partners's 13F filing for Q4 2021, filed 4 Feb 2022.